Literature DB >> 12568736

A pilot study comparing the clinical effects of Jia-Wey Shiau-Yau San, a traditional Chinese herbal prescription, and a continuous combined hormone replacement therapy in postmenopausal women with climacteric symptoms.

Lih Chi Chen1, Yun Tson Tsao, Kun Ying Yen, Yu Fang Chen, Mei Huei Chou, Ming Fang Lin.   

Abstract

OBJECTIVES: Interest in use of alternative remedies for managing menopausal symptoms is increasing exponentially during these years. Jia-Wey Shiau-Yau San (JWSYS), one of the traditional Chinese herbal prescriptions, is a famous herbal remedy used for the management of various menopausal-related symptoms. A randomized, controlled pilot study was performed to evaluate the clinical effects of JWSYS compared with those of a continuous combined hormone replacement therapy, Premelle, on quality of life in non-hysterectomized postmenopausal women.
METHODS: The present trial compared the effect of a l6-week treatment with JWSYS or HRT (Premelle) in postmenopausal women with climacteric symptoms. The Greene Climacteric Scale was used to assess the clinical effects at baseline and after 16 weeks' treatment with either JWSYS or Premelle. The physiological parameters, such as follicle-stimulating hormone and estradiol levels, were also recorded at the same time points.
RESULTS: The results showed that JWSYS had a relatively lower discontinuation rate due to adverse effects, in particular the bleeding and breast tenderness. Both JWSYS and Premelle effectively alleviated most of the menopausal symptoms with no significant differences between treatment groups, whereas the beneficial effects of JWSYS were not mediated by hormone replacement-like effects. Moreover, JWSYS showed a good compliance and safety without estrogenic effects and metabolic alterations.
CONCLUSIONS: It was suggested that JWSYS was a safe and efficacious therapy and might be an alternative choice for relief of climacteric symptoms in postmenopausal women. However, the exact efficacy and clinical roles of JWSYS have not been convincingly demonstrated in this study because of the blinding approach and some statistical concerns, and only the possibility of its efficacy has been raised. Therefore, a blinding trial with more patient numbers to evaluate the efficacy of JWSYS deserves further study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12568736     DOI: 10.1016/s0378-5122(02)00314-6

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  17 in total

Review 1.  Treating gynaecological disorders with traditional Chinese medicine: a review.

Authors:  Jue Zhou; Fan Qu
Journal:  Afr J Tradit Complement Altern Med       Date:  2009-07-03

2.  New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk.

Authors:  Carolyn J Crandall; Aaron K Aragaki; Rowan T Chlebowski; Anne McTiernan; Garnet Anderson; Susan L Hendrix; Barbara B Cochrane; Lewis H Kuller; Jane A Cauley
Journal:  Arch Intern Med       Date:  2009-10-12

3.  Prescription pattern of chinese herbal products for breast cancer in taiwan: a population-based study.

Authors:  Jung-Nien Lai; Chien-Tung Wu; Jung-Der Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-28       Impact factor: 2.629

4.  Chemical and Physical Methods to Analyze a Multicomponent Traditional Chinese Herbal Prescription Using LC-MS/MS, Electron Microscope, and Congo Red Staining.

Authors:  Chia-Ming Lu; Mei-Ling Hou; Lie-Chwen Lin; Tung-Hu Tsai
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-12       Impact factor: 2.629

5.  Coprescription of Chinese herbal medicine and Western medication among female patients with breast cancer in Taiwan: analysis of national insurance claims.

Authors:  Bih-Ru Wang; Yuh-Lih Chang; Tzeng-Ji Chen; Jen-Hwey Chiu; Jing Chong Wu; Min-Shan Wu; Chia-Lin Chou; Yueh-Ching Chou
Journal:  Patient Prefer Adherence       Date:  2014-05-07       Impact factor: 2.711

6.  Prescription patterns of chinese herbal products for osteoporosis in taiwan: a population-based study.

Authors:  Wei-Tai Shih; Yao-Hsu Yang; Pau-Chung Chen
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-10       Impact factor: 2.629

7.  Efficacy and side effects of chinese herbal medicine for menopausal symptoms: a critical review.

Authors:  Lian-Wei Xu; Man Jia; Roland Salchow; Michael Kentsch; Xue-Jun Cui; Hong-Yong Deng; Zhuo-Jun Sun; Lan Kluwe
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-13       Impact factor: 2.629

8.  Room-temperature super-extraction system (RTSES) optimizes the anxiolytic- and antidepressant-like behavioural effects of traditional Xiao-Yao-San in mice.

Authors:  Shih-Hsi Yin; Ching-Cheng Wang; Tain-Junn Cheng; Chia-Yu Chang; Kao-Chang Lin; Wei-Chih Kan; Hsien-Yi Wang; Wenny Mei-Wen Kao; Yen-Liang Kuo; Jian-Chyi Chen; Shun-Lai Li; Chia-Hui Cheng; Jiunn-Jye Chuu
Journal:  Chin Med       Date:  2012-11-07       Impact factor: 5.455

9.  Prescriptions of Chinese Herbal Medicines for Insomnia in Taiwan during 2002.

Authors:  Fang-Pey Chen; Maw-Shiou Jong; Yu-Chun Chen; Yen-Ying Kung; Tzeng-Ji Chen; Fun-Jou Chen; Shinn-Jang Hwang
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-20       Impact factor: 2.629

10.  Hedyotis diffusa Combined with Scutellaria barbata Are the Core Treatment of Chinese Herbal Medicine Used for Breast Cancer Patients: A Population-Based Study.

Authors:  Yuan-Chieh Yeh; Hsing-Yu Chen; Sien-Hung Yang; Yi-Hsien Lin; Jen-Hwey Chiu; Yi-Hsuan Lin; Jiun-Liang Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-09       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.